Investigational Drug Information for Tesofensine
✉ Email this page to a colleague
What is the development status for investigational drug Tesofensine?
Tesofensine is an investigational drug.
There have been 13 clinical trials for Tesofensine.
The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 2003.
The most common disease conditions in clinical trials are Obesity, Prader-Willi Syndrome, and Syndrome. The leading clinical trial sponsors are Saniona, NeuroSearch A/S, and Boehringer Ingelheim.
Summary for Tesofensine
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 1,571 |
| WIPO Patent Applications | 538 |
| Japanese Patent Applications | 48 |
| Clinical Trial Progress | Phase 2 (2003-03-01) |
| Vendors | 33 |
Recent Clinical Trials for Tesofensine
| Title | Sponsor | Phase |
|---|---|---|
| Study of Tesomet With Open-label Extension in Subjects With Prader-Willi Syndrome | Saniona | Phase 2 |
| Phase 2b Study of Tesomet With Open-label Extension in Subjects With Hypothalamic Obesity (HO) | Saniona | Phase 2 |
| 48 Weeks, Study to Evaluate Overall Safety and Tolerability of Co-administration of Tesofensine and Metoprolol in Subjects With Hypothalamic Injury-induced Obesity (HIO) | Saniona | Phase 2 |
Clinical Trial Summary for Tesofensine
Top disease conditions for Tesofensine
Top clinical trial sponsors for Tesofensine
US Patents for Tesofensine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
